Stay updated with breaking news from Caredx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CareDx, Inc (NASDAQ:CDNA – Get Rating) insider Reginald Seeto sold 2,819 shares of the business’s stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $8.13, for a total value of $22,918.47. Following the transaction, the insider now owns 532,177 shares in the company, valued at […]
Record Number of 65 Abstracts Showcasing CareDx Innovation Including Data Showing Clinical Utility of AlloSure Kidney to Guide Immunosuppression Management Experts Review Advancements in... | June 1, 2023
CareDx, Inc. , a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients... | June 1, 2023
CareDx, Inc (NASDAQ:CDNA – Get Rating) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 6,200,000 shares, an increase of 19.2% from the April 30th total of 5,200,000 shares. Based on an average trading volume of 1,380,000 shares, the days-to-cover ratio is presently […]
Equities research analysts at StockNews.com began coverage on shares of CareDx (NASDAQ:CDNA – Get Rating) in a research note issued to investors on Thursday. The firm set a “hold” rating on the stock. A number of other equities research analysts have also recently commented on CDNA. The Goldman Sachs Group dropped their target price on […]